Meloxicam administration in the management of postoperative pain and inflammation associated with caesarean section in beef heifers: Evaluation of reproductive parameters

• Published in: Theriogenology Vol. 175; pp. 148 - 154
• Main Authors: Mauffré, Vincent, Cardot, Thomas, Belbis, Guillaume, Plassard, Vincent, Constant, Fabienne, Bernard, Sandrine, Roch, Nicolas, Bohy, Arnaud, Nehlig, Nicolas, Ponter, Andrew, Grimard, Bénédicte, Guilbert-Julien, Laurence
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01.11.2021
• Subjects: Animal biology; Beef heifers; C-section; Life Sciences; Meloxicam; Non-steroidal anti-inflammatory drug; Pain management; Reproduction; Veterinary medicine and animal Health; Meloxicam; Reproduction; Beef heifers; C-section; Non-steroidal anti-inflammatory drug; Pain management
• ISSN: 0093-691X; 1879-3231; 0093-691X
• DOI: 10.1016/j.theriogenology.2021.09.005

Post-operative pain and inflammation are normal physiological reactions to caesarean section. Their management in cattle have rarely been investigated. This surgical procedure negatively affects reproductive function with, for example, a reduction in fertility resulting in an increase in calving interval. In this multicenter clinical trial, the objective was to evaluate the impact on reproductive performance of meloxicam injected before caesarean section to manage post-operative pain and inflammation. Meloxicam is a non-steroidal anti-inflammatory drug. One hundred and twenty-seven Charolais heifers (n = 127) were recruited from 47 farms in six French veterinary practices in the Burgundy region. The heifers underwent a non-elective standardized caesarean section operation. Heifers were randomly assigned to one of two groups: meloxicam (n = 66), intravenous meloxicam injection before surgery, or control (n = 61). Reproductive performance and health information were recorded from the time of the caesarean section to the next calving or to culling. In our study, meloxicam administration before caesarean section had no effect on the incidence of retained placenta (18.2% of treated vs 25.0% of control cows, p = 0.35). The pregnancy rate was higher in treated than in control cows (83.1% vs 67.8%, p = 0.04 after multivariate analysis) and a survival analysis showed that the median calving interval was 35 days shorter in the meloxicam (t50% = 417 days) compared to the control group (t50% = 452 days, p = 0.05). A trend was also observed for culling rate to be lower in treated (4.7%) compared to control cows (13.3%, p = 0.09). In conclusion, this study suggests that there is a beneficial effect of meloxicam administration before caesarean section on reproductive performance in Charolais heifers. •Meloxicam was associated with higher pregnancy rate.•Meloxicam tended to shorten the calving interval and to reduce the culling rate.•Meloxicam was not associated with higher risk of retained placenta.